{"id":607534,"date":"2022-07-11T18:26:01","date_gmt":"2022-07-11T18:26:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=607534"},"modified":"2022-07-11T18:26:01","modified_gmt":"2022-07-11T18:26:01","slug":"vegfr-inhibitorinduced-handfoot-skin-reaction-market-to-observe-stupendous-growth-during-the-forecast-period-delveinsight-key-companies-onquality-takeda-sinorda-biomedicine-and-others","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/vegfr-inhibitorinduced-handfoot-skin-reaction-market-to-observe-stupendous-growth-during-the-forecast-period-delveinsight-key-companies-onquality-takeda-sinorda-biomedicine-and-others_607534.html","title":{"rendered":"VEGFR Inhibitor-Induced Hand-Foot Skin Reaction Market to Observe Stupendous Growth During the Forecast Period – DelveInsight | Key Companies – OnQuality, Takeda, Sinorda Biomedicine, and others"},"content":{"rendered":"
\n
\"VEGFR<\/a><\/div>\n
\n
Delveinsight Business Research LLP<\/div>\n<\/div>\n<\/div>\n
DelveInsight’s “VEGFR Inhibitor-Induced Hand-Foot Skin Reaction Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the VEGFR Inhibitor-Induced Hand-Foot Skin Reaction Market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).<\/div>\n

The VEGFR Inhibitor-Induced Hand-Foot Skin Reaction market<\/strong> report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice\/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. <\/p>\n

\"VEGFR<\/p>\n

VEGFR Inhibitor-Induced Hand-Foot Skin Reaction: An Overview<\/strong><\/p>\n

Hand-foot skin reaction (HFSR)<\/strong>, also known as hand-foot syndrome<\/strong> or palmar-plantar erythrodysesthesia (PPE)<\/strong>, is an adverse effect of several chemotherapeutic agents. The syndrome is characterized by redness, swelling, pain, and tingling in the palms of the hands and the soles of the feet. <\/p>\n

Callus-like thickened tender blisters with some surrounding erythema are most typically localized to areas of pressure or friction, such as the heel and forefoot. The National Cancer Institute has classified the clinical manifestations by grades, ranging from 1 to 3<\/strong>.<\/p>\n

As per the article by Fischer et al. (2013) titled “The risk of hand-foot skin reaction to axitinib, a novel VEGF inhibitor: a systematic review of literature and meta-analysis”, a total of 984 patients<\/strong> from six clinical trials were available for analysis. The reported incidences of all-grade HFSR ranged between 7.7 %<\/strong> and 75.0 %<\/strong>.<\/em><\/p>\n

VEGFR Inhibitor-Induced Hand-Foot Skin Reaction Market<\/strong><\/a><\/p>\n

The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted VEGFR Inhibitor-Induced Hand-Foot Skin Reaction market size<\/strong> by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies.<\/p>\n

The report gives complete detail of the VEGFR Inhibitor-Induced Hand-Foot Skin Reaction market trend<\/strong> for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, mechanism of action (MoA), competition with other therapies, brand value, and their impact on the market.<\/p>\n

VEGFR Inhibitor-Induced Hand-Foot Skin Reaction Epidemiology<\/strong><\/p>\n

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of diagnosed patient pool and future trends.<\/p>\n

VEGFR Inhibitor-Induced Hand-Foot Skin Reaction Epidemiology Segmentation<\/strong><\/p>\n